Soubrié P[au] - PubMed

Best matches for Soubrié P[au]:

SR 48968, a neurokinin A (NK2) receptor antagonist. Emonds-Alt X et al. Regul Pept. (1993)

Neuropharmacological profile of non-peptide neurotensin antagonists. Gully D et al. Fundam Clin Pharmacol. (1995)

Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique. Soubrié P et al. Neuroscience. (1984)

Search results

Items: 1 to 50 of 225

<< First< Prev

Page of 5

Next >Last >>

Select item 175260151.

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.

Gary-Bobo M, Elachouri G, Gallas JF, Janiak P, Marini P, Ravinet-Trillou C, Chabbert M, Cruccioli N, Pfersdorff C, Roque C, Arnone M, Croci T, Soubrié P, Oury-Donat F, Maffrand JP, Scatton B, Lacheretz F, Le Fur G, Herbert JM, Bensaid M.

Hepatology. 2007 Jul;46(1):122-9.

PMID:: 17526015

Similar articles

Select item 160097042.

The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance.

Jbilo O, Ravinet-Trillou C, Arnone M, Buisson I, Bribes E, Péleraux A, Pénarier G, Soubrié P, Le Fur G, Galiègue S, Casellas P.

FASEB J. 2005 Sep;19(11):1567-9. Epub 2005 Jul 11.

PMID:: 16009704

Similar articles

Select item 159569943.

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.

Depoortère R, Dargazanli G, Estenne-Bouhtou G, Coste A, Lanneau C, Desvignes C, Poncelet M, Heaulme M, Santucci V, Decobert M, Cudennec A, Voltz C, Boulay D, Terranova JP, Stemmelin J, Roger P, Marabout B, Sevrin M, Vigé X, Biton B, Steinberg R, Françon D, Alonso R, Avenet P, Oury-Donat F, Perrault G, Griebel G, George P, Soubrié P, Scatton B.

Neuropsychopharmacology. 2005 Nov;30(11):1963-85.

PMID:: 15956994

Free Article

Similar articles

Select item 158926614.

Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders.

Griebel G, Stemmelin J, Gal CS, Soubrié P.

Curr Pharm Des. 2005;11(12):1549-59. Review.

PMID:: 15892661

Similar articles

Select item 154668985.

Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic alcohol administration combined with repeated re-exposures and withdrawals.

Lallemand F, Soubrié P, De Witte P.

Alcohol Alcohol. 2004 Nov-Dec;39(6):486-92. Epub 2004 Oct 5.

PMID:: 15466898

Similar articles

Select item 152929056.

Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).

Cohen C, Perrault G, Griebel G, Soubrié P.

Neuropsychopharmacology. 2005 Jan;30(1):145-55.

PMID:: 15292905

Free Article

Similar articles

Select item 151312457.

SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization.

Rinaldi-Carmona M, Barth F, Congy C, Martinez S, Oustric D, Pério A, Poncelet M, Maruani J, Arnone M, Finance O, Soubrié P, Le Fur G.

J Pharmacol Exp Ther. 2004 Sep;310(3):905-14. Epub 2004 May 6.

PMID:: 15131245

Similar articles

Select item 151110198.

SSR181507, a putative atypical antipsychotic with dopamine D2 antagonist and 5-HT1A agonist activities: improvement of social interaction deficits induced by phencyclidine in rats.

Boulay D, Depoortère R, Louis C, Perrault G, Griebel G, Soubrié P.

Neuropharmacology. 2004 Jun;46(8):1121-9.

PMID:: 15111019

Similar articles

Select item 150303839.

Specific involvement of neurotensin type 1 receptor in the neurotensin-mediated in vivo dopamine efflux using knock-out mice.

Leonetti M, Brun P, Clerget M, Steinberg R, Soubrié P, Renaud B, Suaud-Chagny MF.

J Neurochem. 2004 Apr;89(1):1-6.

PMID:: 15030383

Free Article

Similar articles

Select item 1477019010.

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity.

Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrié P.

Int J Obes Relat Metab Disord. 2004 Apr;28(4):640-8.

PMID:: 14770190

Similar articles

Select item 1474760911.

SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization.

Gougat J, Ferrari B, Sarran L, Planchenault C, Poncelet M, Maruani J, Alonso R, Cudennec A, Croci T, Guagnini F, Urban-Szabo K, Martinolle JP, Soubrié P, Finance O, Le Fur G.

J Pharmacol Exp Ther. 2004 May;309(2):661-9. Epub 2004 Jan 27.

PMID:: 14747609

Similar articles

Select item 1469942812.

Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression.

Alonso R, Griebel G, Pavone G, Stemmelin J, Le Fur G, Soubrié P.

Mol Psychiatry. 2004 Mar;9(3):278-86, 224.

PMID:: 14699428

Similar articles

Select item 1469876013.

Altered neurotensin mrna expression in mice lacking the dopamine transporter.

Roubert C, Spielewoy C, Soubrié P, Hamon M, Giros B, Betancur C.

Neuroscience. 2004;123(2):537-46.

PMID:: 14698760

Free PMC Article

Similar articles

Select item 1469435414.

Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.

Duarte C, Alonso R, Bichet N, Cohen C, Soubrié P, Thiébot MH.

Neuropsychopharmacology. 2004 May;29(5):911-20.

PMID:: 14694354

Free Article

Similar articles

Select item 1451112615.

The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum.

Kemel ML, Pérez S, Beaujouan JC, Jabourian M, Soubrié P, Glowinski J.

J Neurochem. 2003 Oct;87(2):487-96.

PMID:: 14511126

Free Article

Similar articles

Select item 1290299416.

SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.

Claustre Y, Peretti DD, Brun P, Gueudet C, Allouard N, Alonso R, Lourdelet J, Oblin A, Damoiseau G, Françon D, Suaud-Chagny MF, Steinberg R, Sevrin M, Schoemaker H, George P, Soubrié P, Scatton B.

Neuropsychopharmacology. 2003 Dec;28(12):2064-76.

PMID:: 12902994

Free Article

Similar articles

Select item 1290299317.

SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: Behavioral profile predictive of an atypical antipsychotic activity.

Depoortere R, Boulay D, Perrault G, Bergis O, Decobert M, Françon D, Jung M, Simiand J, Soubrié P, Scatton B.

Neuropsychopharmacology. 2003 Nov;28(11):1889-902.

PMID:: 12902993

Free Article

Similar articles

Select item 1277070018.

Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice.

Poncelet M, Maruani J, Calassi R, Soubrié P.

Neurosci Lett. 2003 Jun 12;343(3):216-8.

PMID:: 12770700

Similar articles

Select item 1274794019.

Control by tachykinin NK(2) receptors of CRF(1) receptor-mediated activation of hippocampal acetylcholine release in the rat and guinea-pig.

Desvignes C, Rouquier L, Souilhac J, Mons G, Rodier D, Soubrié P, Steinberg R.

Neuropeptides. 2003 Apr;37(2):89-97.

PMID:: 12747940

Similar articles

Select item 1268221720.

SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.

Cohen C, Bergis OE, Galli F, Lochead AW, Jegham S, Biton B, Leonardon J, Avenet P, Sgard F, Besnard F, Graham D, Coste A, Oblin A, Curet O, Voltz C, Gardes A, Caille D, Perrault G, George P, Soubrie P, Scatton B.

J Pharmacol Exp Ther. 2003 Jul;306(1):407-20. Epub 2003 Apr 7.

PMID:: 12682217

Similar articles

Select item 1265397421.

Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex.

Barbara JG, Auclair N, Roisin MP, Otani S, Valjent E, Caboche J, Soubrie P, Crepel F.

Eur J Neurosci. 2003 Mar;17(5):981-90.

PMID:: 12653974

Similar articles

Select item 1264459222.

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.

Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F, Soubrié P.

Mol Pharmacol. 2003 Apr;63(4):908-14.

PMID:: 12644592

Similar articles

Select item 1244459823.

Neurotensin enhances glutamate excitotoxicity in mesencephalic neurons in primary culture.

Antonelli T, Tomasini MC, Finetti S, Giardino L, Calzà L, Fuxe K, Soubriè P, Tanganelli S, Ferraro L.

J Neurosci Res. 2002 Dec 15;70(6):766-73.

PMID:: 12444598

Similar articles

Select item 1243854224.

SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin 1 receptor: II. Neurochemical and behavioral characterization.

Steinberg R, Alonso R, Rouquier L, Desvignes C, Michaud JC, Cudennec A, Jung M, Simiand J, Griebel G, Emonds-Alt X, Le Fur G, Soubrié P.

J Pharmacol Exp Ther. 2002 Dec;303(3):1180-8.

PMID:: 12438542

Similar articles

Select item 1243854125.

SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.

Emonds-Alt X, Proietto V, Steinberg R, Oury-Donat F, Vigé X, Vilain P, Naline E, Daoui S, Advenier C, Le Fur G, Maffrand JP, Soubrié P, Pascal M.

J Pharmacol Exp Ther. 2002 Dec;303(3):1171-9.

PMID:: 12438541

Similar articles

Select item 1243579826.

Expression profile and up-regulation of PRAX-1 mRNA by antidepressant treatment in the rat brain.

Chardenot P, Roubert C, Galiègue S, Casellas P, Le Fur G, Soubrié P, Oury-Donat F.

Mol Pharmacol. 2002 Dec;62(6):1314-20.

PMID:: 12435798

Similar articles

Select item 1239925227.

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice.

Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand JP, Soubrie P.

Am J Physiol Regul Integr Comp Physiol. 2003 Feb;284(2):R345-53. Epub 2002 Oct 24.

PMID:: 12399252

Free Article

Similar articles

Select item 1239442128.

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats.

Cohen C, Perrault G, Voltz C, Steinberg R, Soubrié P.

Behav Pharmacol. 2002 Sep;13(5-6):451-63.

PMID:: 12394421

Similar articles

Select item 1238423929.

Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia.

Remaury A, Vita N, Gendreau S, Jung M, Arnone M, Poncelet M, Culouscou JM, Le Fur G, Soubrié P, Caput D, Shire D, Kopf M, Ferrara P.

Brain Res. 2002 Oct 25;953(1-2):63-72.

PMID:: 12384239

Similar articles

Select item 1213073830.

SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties.

Moser PC, Bergis OE, Jegham S, Lochead A, Duconseille E, Terranova JP, Caille D, Berque-Bestel I, Lezoualc'h F, Fischmeister R, Dumuis A, Bockaert J, George P, Soubrié P, Scatton B.

J Pharmacol Exp Ther. 2002 Aug;302(2):731-41.

PMID:: 12130738

Similar articles

Select item 1207075531.

The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.

Leonetti M, Brun P, Sotty F, Steinberg R, Soubrié P, Bert L, Renaud B, Suaud-Chagny MF.

Naunyn Schmiedebergs Arch Pharmacol. 2002 Jun;365(6):427-33. Epub 2002 Apr 26.

PMID:: 12070755

Similar articles

Select item 1205655732.

Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist.

Emonds-Alt X, Proietto V, Steinberg R, Advenier C, Daoui S, Naline E, Gueudet C, Michaud JC, Oury-Donat F, Poncelet M, Vilain P, Le Fur G, Maffrand JP, Soubrié P, Pascal M.

Can J Physiol Pharmacol. 2002 May;80(5):482-8.

PMID:: 12056557

Similar articles

Select item 1202353933.

SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair.

Ferzaz B, Brault E, Bourliaud G, Robert JP, Poughon G, Claustre Y, Marguet F, Liere P, Schumacher M, Nowicki JP, Fournier J, Marabout B, Sevrin M, George P, Soubrie P, Benavides J, Scatton B.

J Pharmacol Exp Ther. 2002 Jun;301(3):1067-78.

PMID:: 12023539

Similar articles

Select item 1195991234.

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

Griebel G, Simiand J, Serradeil-Le Gal C, Wagnon J, Pascal M, Scatton B, Maffrand JP, Soubrie P.

Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6370-5. Epub 2002 Apr 16.

PMID:: 11959912

Free PMC Article

Similar articles

Select item 1190719135.

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders.

Griebel G, Simiand J, Steinberg R, Jung M, Gully D, Roger P, Geslin M, Scatton B, Maffrand JP, Soubrié P.

J Pharmacol Exp Ther. 2002 Apr;301(1):333-45.

PMID:: 11907191

Similar articles

Select item 1190719036.

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization.

Gully D, Geslin M, Serva L, Fontaine E, Roger P, Lair C, Darre V, Marcy C, Rouby PE, Simiand J, Guitard J, Gout G, Steinberg R, Rodier D, Griebel G, Soubrie P, Pascal M, Pruss R, Scatton B, Maffrand JP, Le Fur G.

J Pharmacol Exp Ther. 2002 Apr;301(1):322-32.

PMID:: 11907190

Similar articles

Select item 1188052337.

Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum.

Kemel ML, Pérez S, Godeheu G, Soubrié P, Glowinski J.

J Neurosci. 2002 Mar 1;22(5):1929-36.

PMID:: 11880523

Free PMC Article

Similar articles

Select item 1186182338.

Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist.

Serradeil-Le Gal C, Wagnon J, Simiand J, Griebel G, Lacour C, Guillon G, Barberis C, Brossard G, Soubrié P, Nisato D, Pascal M, Pruss R, Scatton B, Maffrand JP, Le Fur G.

J Pharmacol Exp Ther. 2002 Mar;300(3):1122-30.